The new Roche Elecsys TSH assay conforms with current IFCC C-STFT standards. / Kratzsch, Juergen; Baumann, Nikola A.; Ceriotti, Ferruccio; Lu, Zhong X.; Schott, Matthias; Van Herwaarden, Antonius E.; Henriques Vieira, José Gilberto; Lehmann, Holger; Kasapic, Dusanka; Giovanella, Luca.In: Clinical Chemistry and Laboratory Medicine, 2021.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The new Roche Elecsys TSH assay conforms with current IFCC C-STFT standards
AU - Kratzsch, Juergen
AU - Baumann, Nikola A.
AU - Ceriotti, Ferruccio
AU - Lu, Zhong X.
AU - Schott, Matthias
AU - Van Herwaarden, Antonius E.
AU - Henriques Vieira, José Gilberto
AU - Lehmann, Holger
AU - Kasapic, Dusanka
AU - Giovanella, Luca
N1 - Funding Information: Research funding: The study was funded by Roche Diagnostics International Ltd. Funding Information: The authors would like to thank Michael Rottmann of Roche Diagnostics for his help with the study design and data collection, and Martin Weiss of Roche Diagnostics for his assistance with data curation and analysis. Medical writing support was provided by Angela Corstorphine and Sian-Marie Lucas of Kstorfin Medical Communications Ltd, and Clair Clowes of inScience Communications, Springer Healthcare Ltd, and funded by Roche Diagnostics International Ltd. COBAS, COBAS E, and ELECSYS are trademarks of Roche. All other product names and trademarks are the property of their respective owners. Funding Information: Competing interests: All authors participated in an advisory board for Roche Diagnostics. J.G.H.V. holds stocks in Group Fleury. J.K. has received grants for presentations from Roche and Novartis and a research grant from PES. L.G. has received research grants from Roche Diagnostics, speaker honoraria from Roche Diagnostics, Brahms GmbH, Eisai, Siemens Healthcare and Sanofi-Genzyme, and serves on an advisory board for Roche Diagnostics. N.A.B. has received an honorarium for serving on an advisory board for Roche Diagnostics. M.S. has received an honorarium from Roche for an oral presentation. A.E.V.H has received an honorarium to his institution for serving on an advisory board for Roche Diagnostics. H.L. and D.K. and are employees of Roche Diagnostics. No further competing financial interests exist for F.C. and Z.X.L.
PY - 2021
Y1 - 2021
UR - http://www.scopus.com/inward/record.url?scp=85111751111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111751111&partnerID=8YFLogxK
U2 - 10.1515/cclm-2021-0352
DO - 10.1515/cclm-2021-0352
M3 - Letter
C2 - 34252995
AN - SCOPUS:85111751111
JO - Clinical Chemistry and Laboratory Medicine
JF - Clinical Chemistry and Laboratory Medicine
SN - 1434-6621